263 related articles for article (PubMed ID: 16306476)
1. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.
Wolfe F; Michaud K
Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476
[TBL] [Abstract][Full Text] [Related]
2. Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.
Welsing PM; Severens JL; Hartman M; van Riel PL; Laan RF
Arthritis Rheum; 2004 Dec; 51(6):964-73. PubMed ID: 15593319
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.
Devine EB; Alfonso-Cristancho R; Sullivan SD
Pharmacotherapy; 2011 Jan; 31(1):39-51. PubMed ID: 21182357
[TBL] [Abstract][Full Text] [Related]
4. Can observational studies replace or complement experiment?
van der Linden S; Goldsmith CH; Woodcock J; Nassonova V
J Rheumatol Suppl; 1994 Sep; 41():57-61. PubMed ID: 7799388
[TBL] [Abstract][Full Text] [Related]
5. A simple sample size formula for analysis of covariance in randomized clinical trials.
Borm GF; Fransen J; Lemmens WA
J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
[TBL] [Abstract][Full Text] [Related]
6. Remission in early rheumatoid arthritis.
Ma MH; Scott IC; Kingsley GH; Scott DL
J Rheumatol; 2010 Jul; 37(7):1444-53. PubMed ID: 20516031
[TBL] [Abstract][Full Text] [Related]
7. In quest of the holy grail: efficacy versus effectiveness in rheumatoid arthritis.
Suarez-Almazor ME
J Rheumatol; 2002 Feb; 29(2):209-11. PubMed ID: 11838836
[No Abstract] [Full Text] [Related]
8. Long term treatment of rheumatoid arthritis with rituximab.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
[TBL] [Abstract][Full Text] [Related]
9. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J
Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials: how to cope with medical needs, ethics and timelines.
Rubbert-Roth A; Burmester GR
Ann Rheum Dis; 2010 Jan; 69(1):1-3. PubMed ID: 20007619
[No Abstract] [Full Text] [Related]
11. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
Yukawa N; Mimori T
Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
[TBL] [Abstract][Full Text] [Related]
12. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
13. Rituximab (Rituxan) for rheumatoid arthritis.
Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
[No Abstract] [Full Text] [Related]
14. Rituximab: new indication. In rheumatoid arthritis: for a few patients, with close monitoring.
Prescrire Int; 2007 Oct; 16(91):186-8. PubMed ID: 17926823
[TBL] [Abstract][Full Text] [Related]
15. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
[TBL] [Abstract][Full Text] [Related]
16. Efficacy assessment in trials of combination therapy for rheumatoid arthritis.
Johnson K
J Rheumatol Suppl; 1996 Mar; 44():107-9. PubMed ID: 8833066
[TBL] [Abstract][Full Text] [Related]
17. Sample-size calculations for studies with correlated ordinal outcomes.
Kim HY; Williamson JM; Lyles CM
Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
[TBL] [Abstract][Full Text] [Related]
18. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
Wolfe F; Caplan L; Michaud K
J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
[No Abstract] [Full Text] [Related]
19. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
Harrison MJ; Tricker KJ; Davies L; Hassell A; Dawes P; Scott DL; Knight S; Davis M; Mulherin D; Symmons DP
J Rheumatol; 2005 Dec; 32(12):2330-6. PubMed ID: 16331758
[TBL] [Abstract][Full Text] [Related]
20. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
Porter D
Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
